Dublin, April 01, 2026 (GLOBE NEWSWIRE) — The “Oncology Ablation Market Report 2026” has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive statistics, market size analysis, regional shares, and competitor insights.
The oncology ablation market has seen robust growth, set to expand from $1.45 billion in 2025 to $1.64 billion in 2026 with a CAGR of 12.5%. Historical growth is attributed to rising cancer incidences such as liver, kidney, and lung cancers, and the increasing demand for minimally invasive treatments. This growth is supported by advancements in imaging technologies, hospital expansions, and heightened awareness of ablation alternatives to surgery.
Forecasts indicate the market will reach $2.61 billion by 2030, escalating at a CAGR of 12.4%. This growth will be driven by advancements in targeted and personalized ablation therapies, adoption of percutaneous and laparoscopic techniques, and technological progress in ablation equipment. Moreover, emerging regions are expanding their oncology centers, integrating digital patient management systems. Trends indicate increased use of digital platforms for procedure management, AI-enabled diagnosis, precision medicine, and IoT-enabled device monitoring.
The rising number of cancer diagnoses significantly drives market growth. Factors include aging populations, improved screening, early detection, and environmental factors. The National Cancer Institute anticipates 2,001,140 new cancer cases in the U.S. by May 2024, with prostate, lung, and colorectal cancers accounting for about 48% of male diagnoses. By 2040, incidences could surge to 29.9 million annually. Furthermore, the American Cancer Society reported 1.9 million new U.S. cases in 2022, underscoring the demand for oncology ablation as a treatment option.
Leading market players focus on developing precise ablation systems, real-time integrated imaging solutions, and enhanced safety features. In March 2024, Medtronic Plc secured FDA approval for the OsteoCool 2 bone tumor ablation system, featuring enhancements like four-probe operation, effectively targeting multiple tumor sites. Similarly, AngioDynamics partnered with Immunophotonics in February 2024 to blend ablation devices with immunotherapy in treating solid tumors, advancing interventional immuno-oncology.
Main market players include Medtronic plc, Boston Scientific Corporation, AngioDynamics Inc, and others. North America led the market share in 2025, while the Asia-Pacific region is forecasted for rapid growth. Regions analyzed include Asia-Pacific, Western and Eastern Europe, North America, South America, and others, with specific focus countries like the USA, China, and Germany.
Reasons to Purchase:
- Acquire a global perspective with comprehensive coverage spanning 16 geographies.
- Understand the influence of macroeconomic factors, including geopolitical events, trade policies, inflation trends, and regulatory changes.
- Develop regional and country-focused strategies utilizing localized data insights.
- Identify key growth segments ripe for investment.
- Leverage forecast data to outperform competitors by understanding market drivers and trends.
- Analyze end-user behavior for enhanced customer insights.
- Benchmark against competitors in terms of market share, innovation, and brand stature.
- Evaluate market potential through Total Addressable Market (TAM) calculations and market attractiveness scoring.
- Access reliable, high-quality data for presentations, with report updates and detailed Excel data sheets.
Report Scope
An extensive focus on technologies (Radiofrequency, Microwave, Cryoablation, Irreversible Electroporation Ablation), treatment types, and applications (Kidney, Liver, Breast, Lung, and Prostate Cancer) characterizes the scope of the report. Subsegments include a detailed breakdown by radiofrequency, microwave, cryoablation, and electroporation categories.
Leading companies such as Medtronic plc, Boston Scientific Corporation, and AngioDynamics Inc. are featured, alongside others shaping this market landscape. The geography encompassed includes countries such as Australia, Brazil, China, and the USA, among others, with regional insights on Asia-Pacific, Western and Eastern Europe, and more.
The report includes five years of historical data and a ten-year forecast, delivering data such as market size ratios and GDP proportions, supported by comprehensive market segmentation and competitive analysis.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2026-2030 |
| Estimated Market Value (USD) in 2026 | $1.64 Billion |
| Forecasted Market Value (USD) by 2030 | $2.61 Billion |
| Compound Annual Growth Rate | 12.4% |
| Regions Covered | Global |
The companies featured in this Oncology Ablation market report include:
- Medtronic plc
- Boston Scientific Corporation
- AngioDynamics Inc
- EDAP TMS S.A.
- Merit Medical Systems Inc
- Misonix Inc
- BSD Medical Corporation
- Sonacare Medical
- Chongqing Haifu Medical Technology Co Ltd
- HealthTronics Inc
- Galil Medical Inc
- SonaCare Medical LLC
- BVM Medical Ltd
- BTG International Ltd
- Mermaid Medical
- HistoSonics Inc
- Medigus Ltd
- Miramar Labs Inc
- KLS Martin Group
- Endocare Inc
- InnovaCore Inc
- IceCure Medical Inc
- RF Medical Co Ltd
- CSA Medical Inc
For more information about this report visit https://www.researchandmarkets.com/r/68t2ww
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
